Tauvid Receives Approval for Tau Pathology Imaging

Alternative Medicine Drug Resistance News

MONDAY, June 1, 2020 — Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food and Drug Administration announced…

Leave a Reply

Your email address will not be published. Required fields are marked *